Reprieve Cardiovascular

Led by a seasoned management team with extensive experience in the medical device industry.

Launch date

2018

Employees

Market cap

Enterprise valuation

Milford Connecticut (HQ)

Date	Investors	Amount	Round
Sep 2018	Abiomed	$7.0m	Early VC
Aug 2020	N/A	$15.0m	Early VC
Jun 2022*	N/A	$15.0m	Early VC
Feb 2024*	Arboretum Ventures Sante Ventures Lightstone Ventures Deerfield Genesis Capital	$42.0m	Series A
Total Funding		€71.8m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Reprieve Cardiovascular